Peeling Back The Layers: Exploring Pacira BioSciences Through Analyst Insights
Peeling Back The Layers: Exploring Pacira BioSciences Through Analyst Insights
剖析Pacira Biosciences，了解分析師觀點
Analysts' ratings for Pacira BioSciences (NASDAQ:PCRX) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
在過去的季度裏，對Pacira BioSciences（納斯達克：PCRX）的分析師評級從看好到看淡都有，共有6位分析師提供。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您將找到他們最近的評級摘要，揭示了過去30天內情緒的變化，並將它們與前幾個月進行比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $47.17, along with a high estimate of $57.00 and a low estimate of $38.00. Experiencing a 2.54% decline, the current average is now lower than the previous average price target of $48.40.
爲提供更深入的見解，分析師們已經制定了12個月的股價目標，平均目標爲47.17美元，最高估值爲57.00美元，最低估值爲38.00美元。當前平均數下跌了2.54%，現在的平均目標價低於之前的平均目標價48.40美元。
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級：更深入的了解
A clear picture of Pacira...
通過對最近...
登入免費觀看全文
登入/註冊